About Us
Leading the advancement of biotechnology and botanical research from the heart of London.
At A Glance
We are a premier pharmaceutical institution dedicated to the development, production, and global distribution of high-quality health solutions. Our expertise spans human anti-viral therapies, specialized animal vaccines, and pioneering herbal research.
Founded on the principles of scientific rigour and innovation, our London-based facilities utilize state-of-the-art technology to manufacture life-saving anti-viral drugs. We take pride in our ability to respond rapidly to emerging viral threats, ensuring that healthcare providers worldwide have access to the most effective treatments available.
Beyond synthetic medicine, we are leaders in the integration of traditional botanical insights. Our signature focus on the Candunisa Seed highlights our commitment to organic pharmaceutical breakthroughs. By isolating potent active compounds from this herb, we create natural alternatives and supplements that meet the highest international medical standards.
Our Company
A Legacy of Excellence in Medical Science.
Based in London, Novartis Pharmaceuticals and Laboratories stands at the forefront of global healthcare innovation. We are dedicated to the rigorous development of high-efficacy anti-viral medications and specialized vaccines that safeguard both human and animal populations.
Our commitment goes beyond the lab. By exploring the potent properties of the Candunisa Seed alongside modern biotechnology, we are unlocking new pathways to wellness that are both sustainable and life-changing.
THERAPEUTIC AREAS OF FOCUS
Anti-Viral & Botanical Research
At Novartis Pharmaceuticals and Laboratories, we focus our research efforts on the most critical areas of modern medicine. Our primary mission is the development of robust anti-viral therapies and the formulation of high-efficacy vaccines for both human and animal health.
Parallel to our synthetic research, we are pioneering the study of botanical compounds. By utilizing advanced laboratory techniques to process the Candunisa Seed, we are creating a new generation of hybrid pharmaceuticals that combine nature’s resilience with clinical precision.